/4890.T
4890.T Stock - Tsubota Laboratory Incorporated
Healthcare|Medical - PharmaceuticalsJPX
$359.00+1.70%
+$6.00 (+1.70%) • Dec 24
58
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.52
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.51
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $394.90
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4890.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$355.41 – $362.59
TARGET (TP)$412.85
STOP LOSS$330.28
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.74
52W High$460.00
52W Low$284.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.36B | $673.53M | $954.69M | $640.92M | $687.50M |
| Gross Profit | $1.18B | $21.38M | $719.14M | $557.02M | $606.76M |
| Gross Margin | 86.7% | 3.2% | 75.3% | 86.9% | 88.3% |
| Operating Income | $237.05M | $-649,554,000 | $167.03M | $136.17M | $250.24M |
| Net Income | $205.77M | $-641,317,000 | $90.18M | $153.32M | $201.61M |
| Net Margin | 15.2% | -95.2% | 9.4% | 23.9% | 29.3% |
| EPS | $8.04 | $-25.15 | $3.66 | $6.77 | $8.97 |
Company Overview
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4890.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-5.10
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 11, 2025 | — | $-5.10 | — | — |
Q3 2025 | Aug 6, 2025 | — | $-7.89 | — | — |
Q2 2025 | May 12, 2025 | — | $4.73 | — | — |
Q1 2025 | Feb 12, 2025 | — | $1.58 | — | — |
Q4 2024 | Nov 13, 2024 | — | $8.50 | — | — |
Q3 2024 | Aug 13, 2024 | — | $-6.83 | — | — |
Q2 2024 | May 13, 2024 | — | $12.28 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-25.90 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-6.61 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-4.92 | — | — |
Q2 2023 | May 12, 2023 | — | $-4.41 | — | — |
Q4 2022 | Dec 31, 2022 | — | $4.86 | — | — |
Q4 2022 | Nov 10, 2022 | — | $5.65 | — | — |
Q3 2022 | Sep 30, 2022 | — | $4.90 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4890.T
What is 4890.T's current stock price?
Tsubota Laboratory Incorporated (4890.T) is currently trading at $359.00 per share. The stock has moved +1.70% today.
What is the analyst price target for 4890.T?
No analyst price targets are currently available for this stock.
What sector is Tsubota Laboratory Incorporated in?
Tsubota Laboratory Incorporated operates in the Healthcare sector, specifically within the Medical - Pharmaceuticals industry. The company is traded on the JPX exchange.
What is 4890.T's market cap?
Tsubota Laboratory Incorporated has a market capitalization of $9.21 billion, making it a mid-cap company.
Does 4890.T pay dividends?
No, Tsubota Laboratory Incorporated does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector177A.T
Kohjin Bio Co., Ltd.
$1461.00
Mkt Cap: $7.5B
190A.T
Chordia Therapeutics Inc.
$106.00
Mkt Cap: $7.3B
3628.T
Data Horizon Corporation
$500.00
Mkt Cap: $6.3B
4524.T
Morishita Jintan Co., Ltd.
$2153.00
Mkt Cap: $8.8B
4597.T
Solasia Pharma K.K.
$28.00
Mkt Cap: $7.2B
5187.T
Create Medic Co., Ltd.
$1052.00
Mkt Cap: $8.9B
6557.T
AIAI Group Corporation
$1410.00
Mkt Cap: $9.3B
7096.T
StemCell Institute Inc.
$758.00
Mkt Cap: $7.7B
9218.T
Mental Health Technologies Co.,Ltd.
$865.00
Mkt Cap: $9.0B
9265.T
Yamashita Health Care Holdings,Inc.
$3300.00
Mkt Cap: $8.2B
Explore stocks similar to 4890.T for comparison